NCT05115318View on ClinicalTrials.gov

The Effect of Medical Cannabis on Tics, Premonitory Urge and Psychiatric Comorbidity in Adults With Tourette Syndrome

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

July 1, 2020

Primary Completion Date

March 31, 2021

Study Completion Date

March 31, 2021

Conditions

Tourette SyndromeCannabis

Interventions

DRUG

Medical Cannabis

Patients with GTS were assessed before, 4 and 12 weeks after Medical cannabis initiation for consumption habits, efficacy and side effect profile

Trial Locations (1)

5522621

Tel-Aviv Medical Center, Tel Aviv

All Listed Sponsors

lead

Tel-Aviv Sourasky Medical Center

OTHER_GOV

NCT05115318 - The Effect of Medical Cannabis on Tics, Premonitory Urge and Psychiatric Comorbidity in Adults With Tourette Syndrome | Biotech Hunter | Biotech Hunter